Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Oct 7;106(12):dju321.
doi: 10.1093/jnci/dju321. Print 2014 Dec.

Words matter: distinguishing "personalized medicine" and "biologically personalized therapeutics"

Nathan I Cherny  1 , Elisabeth G E de Vries  2 , Linda Emanuel  2 , Lesley Fallowfield  2 , Prudence A Francis  2 , Alberto Gabizon  2 , Martine J Piccart  2 , David Sidransky  2 , Lior Soussan-Gutman  2 , Chariklia Tziraki  2
Affiliations

Words matter: distinguishing "personalized medicine" and "biologically personalized therapeutics"

Nathan I Cherny et al. J Natl Cancer Inst. .

Abstract

"Personalized medicine" has become a generic term referring to techniques that evaluate either the host or the disease to enhance the likelihood of beneficial patient outcomes from treatment interventions. There is, however, much more to personalization of care than just identifying the biotherapeutic strategy with the highest likelihood of benefit. In its new meaning, "personalized medicine" could overshadow the individually tailored, whole-person care that is at the bedrock of what people need and want when they are ill. Since names and definitional terms set the scope of the discourse, they have the power to define what personalized medicine includes or does not include, thus influencing the scope of the professional purview regarding the delivery of personalized care. Taxonomic accuracy is important in understanding the differences between therapeutic interventions that are distinguishable in their aims, indications, scope, benefits, and risks. In order to restore the due emphasis to the patient and his or her needs, we assert that it is necessary, albeit belated, to deconflate the contemporary term "personalized medicine" by taxonomizing this therapeutic strategy more accurately as "biologically personalized therapeutics" (BPT). The scope of truly personalized medicine and its relationship to biologically personalized therapeutics is described, emphasizing that the best of care must give due recognition and emphasis to both BPT and truly personalized medicine.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
The relationship between personalized medicine and biologically personalized therapeutics (BPT).
See this image and copyright information in PMC

References

    1. Weston AD, Hood L. Systems biology, proteomics, and the future of health care: Toward predictive, preventative, and personalized medicine. J Proteome Res. 2004;3(2):179–196., - PubMed
    1. Ng PC, Venter JC, Murray SS, Levy S. An agenda for personalized medicine. Nature. 2009;461(7265):724–726. - PubMed
    1. Schleidgen S, Klingler C, Bertram T, Rogowski WH, Marckmann G. What is personalized medicine: sharpening a vague term based on a systematic literature review. BMC Med Ethics. 2013;14. - PMC - PubMed
    1. Miller CR, McLeod HL. Pharmacogenomics of cancer chemotherapy-induced toxicity. J Support Oncol. 2007;5(1):9–14. - PubMed
    1. Sweeney BP. Pharmacogenomics and anaesthesia: explaining the variability in response to opiates. European J Anaesthesiol. 2007;24(3):209–212. - PubMed